Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Vicor
VICR
$10.2B
| $6.51M | ﹤0.01% |
154,696
+3,239
| +2% | +$121K |
|
2127
Vestis
VSTS
$1.88B
| $6.51M | ﹤0.01% |
436,976
+80,621
| +23% | +$1.08M |
|
2128
Oxford Industries
OXM
$552M
| $6.5M | ﹤0.01% |
74,875
-589
| -0.8% | -$54.2K |
|
2129
J&J Snack Foods
JJSF
$1.71B
| $6.49M | ﹤0.01% |
37,687
-4,236
| -10% | -$711K |
|
|
CSGS
2130
DELISTED
CSG Systems International
CSGS
| $6.48M | ﹤0.01% |
133,281
-12,937
| -9% | -$590K |
|
2131
Fortrea Holdings
FTRE
$1.75B
| $6.48M | ﹤0.01% |
324,059
+62,795
| +24% | +$1.48M |
|
2132
nLIGHT
LASR
$3.17B
| $6.48M | ﹤0.01% |
605,965
+38,056
| +7% | +$430K |
|
2133
Protagonist Therapeutics
PTGX
$9.44B
| $6.47M | ﹤0.01% |
+143,807
| New | +$5.81M |
|
2134
Dolby
DLB
$5.79B
| $6.46M | ﹤0.01% |
84,366
-6,081
| -7% | -$453K |
|
2135
Hurco Companies Inc
HURC
$143M
| $6.45M | ﹤0.01% |
306,188
+7,636
| +3% | +$131K |
|
2136
Bank of Marin Bancorp
BMRC
$459M
| $6.45M | ﹤0.01% |
321,116
+5,575
| +2% | +$110K |
|
2137
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
| $6.44M | ﹤0.01% |
172,114
-283,328
| -62% | -$10.5M |
|
2138
IES Holdings
IESC
$15.2B
| $6.43M | ﹤0.01% |
32,234
+11,741
| +57% | +$1.9M |
|
2139
Helios Technologies
HLIO
$2.76B
| $6.43M | ﹤0.01% |
134,871
| – | – |
|
|
ARCH
2140
DELISTED
Arch Resources, Inc.
ARCH
| $6.43M | ﹤0.01% |
46,548
-6,174
| -12% | -$851K |
|
2141
Collegium Pharmaceutical
COLL
$956M
| $6.41M | ﹤0.01% |
166,017
+60,026
| +57% | +$2.14M |
|
2142
908 Devices
MASS
$364M
| $6.39M | ﹤0.01% |
1,842,846
-39,745
| -2% | -$176K |
|
2143
iShares US Tech Breakthrough Multisector ETF
TECB
$489M
| $6.39M | ﹤0.01% |
124,796
+17,916
| +17% | +$889K |
|
2144
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.83B
| $6.38M | ﹤0.01% |
60,426
+346
| +0.6% | +$35.3K |
|
2145
PRA Group
PRAA
$755M
| $6.37M | ﹤0.01% |
284,900
-20,371
| -7% | -$454K |
|
2146
Goosehead Insurance
GSHD
$2.32B
| $6.37M | ﹤0.01% |
71,316
-9,153
| -11% | -$724K |
|
2147
Okta
OKTA
$25.8B
| $6.37M | ﹤0.01% |
85,624
-18,443
| -18% | -$1.61M |
|
|
BRKL
2148
DELISTED
Brookline Bancorp
BRKL
| $6.36M | ﹤0.01% |
630,237
+205,776
| +48% | +$2.02M |
|
2149
Myriad Genetics
MYGN
$312M
| $6.35M | ﹤0.01% |
231,819
-21,599
| -9% | -$585K |
|
2150
GrafTech
EAF
$212M
| $6.34M | ﹤0.01% |
479,943
-78,338
| -14% | -$653K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.